DK1423154T3 - Hydrogeneret ricinusolie dispergeret i et lipid til farmaceutisk elegante topiske salver - Google Patents

Hydrogeneret ricinusolie dispergeret i et lipid til farmaceutisk elegante topiske salver

Info

Publication number: DK1423154T3
Authority: DK; Denmark
Prior art keywords: castor oil; lipid; hydrogenated castor; pharmaceutically elegant; oil dispersed
Prior art date: 2001-09-04

Application number

DK02768363T

Other languages

English (en)

Inventor

David P Jones

David W Hobson

Pilar P Duque

Original Assignee

Healthpoint Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-04

Filing date

2002-07-29

Publication date

2009-01-26

2002-07-29 Application filed by Healthpoint Ltd filed Critical Healthpoint Ltd

2009-01-26 Application granted granted Critical

2009-01-26 Publication of DK1423154T3 publication Critical patent/DK1423154T3/da

Links

239000004359 castor oil Substances 0.000 title abstract 4
235000019438 castor oil Nutrition 0.000 title abstract 4
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 title abstract 4
239000002674 ointment Substances 0.000 title abstract 2
150000002632 lipids Chemical class 0.000 title 1
230000000699 topical effect Effects 0.000 title 1
239000000843 powder Substances 0.000 abstract 2
230000008018 melting Effects 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229940100615 topical ointment Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Chemistry (AREA)
Birds (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

DK02768363T 2001-09-04 2002-07-29 Hydrogeneret ricinusolie dispergeret i et lipid til farmaceutisk elegante topiske salver DK1423154T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/945,903 US6479060B1 (en)	2001-09-04	2001-09-04	Elegant hydrogenated castor oil ointments
PCT/US2002/023954 WO2003020203A2 (en)	2001-09-04	2002-07-29	Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments

Publications (1)

Publication Number	Publication Date
DK1423154T3 true DK1423154T3 (da)	2009-01-26

Family

ID=25483673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02768363T DK1423154T3 (da)	2001-09-04	2002-07-29	Hydrogeneret ricinusolie dispergeret i et lipid til farmaceutisk elegante topiske salver

Country Status (15)

Country	Link
US (1)	US6479060B1 (da)
EP (1)	EP1423154B1 (da)
JP (1)	JP4115391B2 (da)
KR (2)	KR100764278B1 (da)
CN (1)	CN100463697C (da)
AT (1)	ATE413861T1 (da)
AU (1)	AU2002330929B2 (da)
BR (1)	BR0212286A (da)
CA (1)	CA2459239C (da)
DE (1)	DE60229855D1 (da)
DK (1)	DK1423154T3 (da)
ES (1)	ES2315400T3 (da)
MX (1)	MXPA04001969A (da)
PT (1)	PT1423154E (da)
WO (1)	WO2003020203A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US9211259B2 (en)	2002-11-29	2015-12-15	Foamix Pharmaceuticals Ltd.	Antibiotic kit and composition and uses thereof
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
ES2532906T5 (es)	2002-10-25	2022-03-23	Foamix Pharmaceuticals Ltd	Espuma cosmética y farmacéutica
US8795693B2 (en)	2003-08-04	2014-08-05	Foamix Ltd.	Compositions with modulating agents
US7785584B2 (en) *	2003-08-13	2010-08-31	Healthpoint, Ltd.	Ointment wound spray
US20050048105A1 (en) *	2003-08-29	2005-03-03	Mcnulty Amy K.	Protease inhibitor compositions for prevention and treatment of skin conditions
US20050100621A1 (en) *	2003-11-07	2005-05-12	Popp Karl F.	Dermatological compositions
US20060264505A1 (en) *	2003-11-07	2006-11-23	Stiefel Laboratories, Inc.	Dermatological compositions
US20050281806A1 (en) *	2004-06-16	2005-12-22	Collegium Pharmaceutical, Inc., Delaware	Compositions for topical enzymatic debridement
US8211449B2 (en) *	2004-06-24	2012-07-03	Dpt Laboratories, Ltd.	Pharmaceutically elegant, topical anhydrous aerosol foam
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AR065378A1 (es) *	2007-02-16	2009-06-03	Procter & Gamble	Articulo absorbente con locion que comprende un material de polipropilenglicol
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en)	2007-11-30	2009-06-04	Foamix Ltd.	Foam containing benzoyl peroxide
WO2009072007A2 (en)	2007-12-07	2009-06-11	Foamix Ltd.	Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20120087872A1 (en)	2009-04-28	2012-04-12	Foamix Ltd.	Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (en)	2009-07-29	2017-04-11	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
KR101102857B1 (ko) *	2009-08-07	2012-01-10	남연우	주방용기
US10029013B2 (en)	2009-10-02	2018-07-24	Foamix Pharmaceuticals Ltd.	Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
RU2585373C2 (ru)	2009-12-08	2016-05-27	Смит & Невью Ортопедикс АГ	Ферментная композиция и способ обработки ран
US20130053353A1 (en) *	2010-05-04	2013-02-28	Foamix Ltd.	Compositions, gels and foams with rheology modulators and uses
US9011931B1 (en)	2011-01-26	2015-04-21	Libby Robinson	Wound dressing composition and method of use
BR112013020770A2 (pt) *	2011-02-15	2019-08-27	Allergan, Inc.	composições de creme farmacêutico de oximetazolina para tratamento de sintomas de rosácea
CN103687610A (zh)	2011-05-12	2014-03-26	史密夫和内修整形外科股份公司	含有蜂蜜曲霉蛋白酶的伤口清创组合物和使用其治疗伤口的方法
WO2013170128A1 (en)	2012-05-11	2013-11-14	Smith & Nephew, Inc.	Use of seaprose to remove bacterial biofilm
AU2017304271B2 (en)	2016-07-27	2024-07-18	Smith & Nephew, Inc.	Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
MX377365B (es)	2016-09-08	2025-03-10	Journey Medical Corp	Composiciones y métodos para tratar rosácea y acné.
EP3573622B1 (en)	2017-01-30	2023-10-18	Smith & Nephew, Inc.	Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
US12029809B2 (en) *	2021-06-10	2024-07-09	Pauleine Prospere	Hair or skin treatment composition and methods of preparation and use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB892450A (en) *	1959-11-18	1962-03-28	Ici Ltd	Improvements in or relating to pharmaceutical compositions comprising ethylthiocarbonyl compounds
US3314972A (en) *	1965-05-21	1967-04-18	Warner Lambert Pharmaceutical	Indolo[3, 2-c]thiopyrylium compounds and intermediates therefor
US5021429A (en) *	1977-05-17	1991-06-04	Allen & Hansburys Limited	Pharmacologically active aminoalkylphenyl compounds and their use
JPS546002A (en) *	1977-06-17	1979-01-17	Chuo Yuka	Lithium soappbase lubricating grease compositions and production thereof
DE2924005C2 (de)	1979-06-13	1984-07-05	Sanol Schwarz-Monheim Gmbh, 4019 Monheim	Isosorbiddinitrat enthaltendes Mittel
NZ196700A (en)	1980-04-18	1983-04-12	Smith & Nephew Ass	Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
US4334546A (en) *	1980-09-08	1982-06-15	Kolmar Laboratories Inc.	Cosmetic pencil
US5102656A (en)	1983-07-29	1992-04-07	The Mennen Company	Antiperspirant creams
DE3409720A1 (de) *	1984-03-16	1985-09-19	Bayer Ag, 5090 Leverkusen	Strukturviskos eingestellte silikonpasten und deren verwendung als abformmassen
US5639724A (en)	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
IT1183530B (it)	1985-03-29	1987-10-22	Monteluos S P A	Composizioni per cosmesi comprendente perfluoropolieteri
IT1197056B (it) *	1986-08-01	1988-11-25	Intercos Italiana	Pomata per mascherare difetti della pelle e cicatrici
DE69010076T2 (de)	1989-05-25	1994-12-08	Takeda Chemical Industries Ltd	Transdermales therapeutisches Mittel.
NZ260408A (en) *	1993-05-10	1996-05-28	Euro Celtique Sa	Controlled release preparation comprising tramadol
GB9405304D0 (en)	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
DE782855T1 (de)	1994-10-05	1998-05-28	Helsinn Healthcare Sa	Antiinflammatorische wirkstoffe zur aüsserlichen anwendung
KR100192149B1 (ko)	1994-10-24	1999-06-15	이시노 요시푸사	경피 투여형 제제
GB9422154D0 (en)	1994-11-03	1994-12-21	Euro Celtique Sa	Pharmaceutical compositions and method of producing the same
JP4010574B2 (ja)	1994-12-05	2007-11-21	電気化学工業株式会社	皮膚外用剤
RO113156B1 (ro) *	1995-03-10	1998-04-30	Icerp Sa	UNSOARE DE LITIU Șl PROCEDEU DE OBȚINERE A ACESTEIA
US6063762A (en)	1997-12-05	2000-05-16	Chong Kun Dang Corp.	Cyclosporin-containing microemulsion preconcentrate composition
US6267970B1 (en) *	1998-03-23	2001-07-31	Avon Products, Inc.	Cream cosmetic base with powdery feel
IT1302275B1 (it) *	1998-09-25	2000-09-05	Giorgio Panin	Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
US6262117B1 (en) *	1999-02-18	2001-07-17	Allergan Sales, Inc.	Method and composition for treating acne

2001
- 2001-09-04 US US09/945,903 patent/US6479060B1/en not_active Expired - Lifetime
2002
- 2002-07-29 JP JP2003524517A patent/JP4115391B2/ja not_active Expired - Fee Related
- 2002-07-29 PT PT02768363T patent/PT1423154E/pt unknown
- 2002-07-29 DK DK02768363T patent/DK1423154T3/da active
- 2002-07-29 CA CA002459239A patent/CA2459239C/en not_active Expired - Fee Related
- 2002-07-29 AT AT02768363T patent/ATE413861T1/de active
- 2002-07-29 BR BRPI0212286-3A patent/BR0212286A/pt not_active IP Right Cessation
- 2002-07-29 KR KR1020067014425A patent/KR100764278B1/ko not_active Expired - Fee Related
- 2002-07-29 KR KR1020047003208A patent/KR100638417B1/ko not_active Expired - Fee Related
- 2002-07-29 AU AU2002330929A patent/AU2002330929B2/en not_active Ceased
- 2002-07-29 MX MXPA04001969A patent/MXPA04001969A/es active IP Right Grant
- 2002-07-29 DE DE60229855T patent/DE60229855D1/de not_active Expired - Lifetime
- 2002-07-29 CN CNB028221044A patent/CN100463697C/zh not_active Expired - Fee Related
- 2002-07-29 ES ES02768363T patent/ES2315400T3/es not_active Expired - Lifetime
- 2002-07-29 EP EP02768363A patent/EP1423154B1/en not_active Expired - Lifetime
- 2002-07-29 WO PCT/US2002/023954 patent/WO2003020203A2/en not_active Ceased

Also Published As

Publication number	Publication date
DE60229855D1 (de)	2008-12-24
KR20040041597A (ko)	2004-05-17
AU2002330929B2 (en)	2005-06-16
CA2459239A1 (en)	2003-03-13
WO2003020203A2 (en)	2003-03-13
EP1423154A2 (en)	2004-06-02
ATE413861T1 (de)	2008-11-15
ES2315400T3 (es)	2009-04-01
KR100638417B1 (ko)	2006-10-24
JP2005527468A (ja)	2005-09-15
EP1423154A4 (en)	2007-08-15
JP4115391B2 (ja)	2008-07-09
WO2003020203A3 (en)	2003-07-10
EP1423154B1 (en)	2008-11-12
HK1065963A1 (en)	2005-03-11
KR20060086460A (ko)	2006-07-31
CN100463697C (zh)	2009-02-25
CN1610563A (zh)	2005-04-27
MXPA04001969A (es)	2004-07-08
US6479060B1 (en)	2002-11-12
BR0212286A (pt)	2006-05-23
PT1423154E (pt)	2009-01-30
KR100764278B1 (ko)	2007-10-05
CA2459239C (en)	2005-06-14

Publication	Publication Date	Title
DK1423154T3 (da)	2009-01-26	Hydrogeneret ricinusolie dispergeret i et lipid til farmaceutisk elegante topiske salver
PT977562E (pt)	2006-05-31	Metodos e composicoes para administracao de taxanos
DK1699474T4 (da)	2013-12-02	Probiotiske tabletformuleringer
DE60132077D1 (de)	2008-02-07	Vitaminzusammenstellung mit verzögerter freigabe
CA2469369A1 (en)	2003-06-19	Compositions containing both sedative and non-sedative antihistamines
DE60127457D1 (de)	2007-05-03	Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
AU6408298A (en)	1998-09-29	Essential oil composition
ATE247953T1 (de)	2003-09-15	Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
IT1263840B (it)	1996-09-04	Formulazioni orali di ubidecarenone in forma di capsule
DE69923336D1 (de)	2005-02-24	Oral anzuwendende buprenorphinhaltige arzneimittel
PT1414467E (pt)	2006-09-29	Tratamento topico da mastalgia
AR046226A1 (es)	2005-11-30	Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
UA37206C2 (uk)	2001-05-15	Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення
DK1372396T3 (da)	2009-03-02	Pesticidpræparat
IT1299264B1 (it)	2000-02-29	Composizioni farmaceutiche topiche utili per il trattamento di patologie cutanee su base infiammatoria, immunitaria o proliferativa
DE602005025339D1 (de)	2011-01-27	Flavonoide und Tocotrienole enthaltende Zusammensetzungen und deren Verwendungen
PT938339E (pt)	2002-10-31	Formulacoes para utilizacao topica
Groenendaal–van de Meent et al.	2010	YM150, an oral direct inhibitor of factor Xa, demonstrated a predictable and dose-proportional pharmacokinetic/pharmacodynamic profile after single and multiple dosing: results from three studies
CN106726916A (zh)	2017-05-31	一种玫瑰精油
BR0001144B1 (pt)	2013-10-22	Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
ATE340588T1 (de)	2006-10-15	Pharmazeutische zusammensetzung enthaltend träger für pharmakologisch aktive produkte wobei die träger auf vitamin e, papain und hyaluronidase basieren
AU2003202550A1 (en)	2003-07-24	Pharmaceutical formulations with modified release
AR039604A1 (es)	2005-03-02	Utilizacion de una sal de acido l-ascorbico para la preparacion de una composicion farmaceutica, para uso oftalmico topico, capaz de mejorar el nivel de acido l-ascorbico en el ojo
EA200101157A1 (ru)	2002-06-27	14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
PA8589401A1 (es)	2004-07-20	Derivados de indolilo